Protection of PD-1 against LPS-induced endotoxemia and the underlying mechanism

YANG Li-Fen; HE Fang; ZHANG Jian; YIN Fei

PDF(952 KB)

Chinese Journal of Contemporary Pediatrics ›› 2010, Vol. 12 ›› Issue (10) : 812-815.

EXPERIMENTAL RESEARCH

Protection of PD-1 against LPS-induced endotoxemia and the underlying mechanism

YANG Li-Fen, HE Fang, ZHANG Jian, YIN Fei

Author information +

History +

Abstract

OBJECTIVE: Gram-negative bacteria-induced multiple organ failure/dysfunction syndrome (MOF/MODS) is one of the leading causes of death through the world. The member of immunoglobulin family programmed death-1 (PD-1) is a negative immune regulator. This study investigated the protective effect of PD-1 as well as the underlying mechanism in LPS-induced endotoxemia. METHODS: Ten PD-1+/+ and ten PD-1 knockout (PD-1/) mice were injected peritoneally with LPS (10 mg/kg), and the survival was observed within 72 hrs after LPS injection. The other 40 PD-1+/+ and 40 PD-1/mice were injected peritoneally with LPS (5 mg/kg). Blood samples were collected before injection and 1.5, 3 and 6 hrs after LPS injection (n=10 each time point). Serum levels of various inflammatory mediators were measured using ELISA. RESULTS: The survival rate in PD-1/mice was noticeably lower than that in PD-1+/+ mice after 10 mg/kg LPS injection. Serum levels of inflammatory mediators TNF-α, IL-1β, IL-12 and IL-17 in PD-1/mice were higher than those in PD-1+/+ mice after 5 mg/kg LPS injection. CONCLUSIONS: PD-1 can protect mice from LPS-induced endotoxemia probably through its regulation on inflammatory mediator production.［Chin J Contemp Pediatr, 2010, 12 (10):812-815］

Key words

Gene knockout / Endotoxemia / Programmed death-1 / Mice

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

YANG Li-Fen, HE Fang, ZHANG Jian, YIN Fei. Protection of PD-1 against LPS-induced endotoxemia and the underlying mechanism[J]. Chinese Journal of Contemporary Pediatrics. 2010, 12(10): 812-815

References

［1］Annane D, Bellissant E, Cavaillon JM. Septic shock ［J］. Lancet, 2005, 365 (9453): 63-78.
［2］Karima R, Matsumoto S, Higashi H, Matsushima K. The molecular pathogenesis of endotoxic shock and organ failure ［J］. Mol Med Today, 1999, 5 (3): 123-132.
［3］Keir ME, Butte MJ, Freeman GJ, Sharpe AH. PD-1 and its ligands in tolerance and immunity ［J］. Annu Rev Immunol, 2008, 26: 677-704.
［4］Sharpe AH, Wherry EJ, Ahmed R, Freeman GJ. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection ［J］. Nat Immunol, 2007, 8 (3): 239-245.
［5］Nishimura H, Honjo T. PD-1: an inhibitory immunoreceptor involved in peripheral tolerance ［J］. Trends Immunol, 2002, 22 (5): 265-268.
［6］Nishimura H, Nose M, Hiai H, Minato N, Honjo T. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor ［J］. Immunity, 1999, 11 (2): 141-151.
［7］Okazaki T, Tanaka Y, Nishio R, Mitsuiye T, Mizoguchi A, Wang J, et al. Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice ［J］. Nat Med, 2003, 9 (12): 1477-1483.
［8］Nishimura H, Okazaki T, Tanaka Y, Nakatani K, Hara M, Matsumori A, et al. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice ［J］. Science, 2001, 291(5502): 319-322.
［9］Zhao Q, Wang X, Nelin LD, Yao Y, Matta R, Manson ME, et al. MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock ［J］. J Exp Med, 2006, 203 (1): 131-140.
［10］Bachmaier K, Toya S, Gao X, Triantafillou T, Garrean S, Park GY, et al. E3 ubiquitin ligase Cblb regulates the acute inflammatory response underlying lung injury ［J］. Nat Med, 2007, 13(8): 920-926.
［11］Wynn J, Cornell TT, Wong HR, Shanley TP, Wheeler DS. The host response to sepsis and developmental impact ［J］. Pediatrics, 2010, 125 (5): 1031-1041.
［12］Peleg AY, Hooper DC. Hospital-acquired infections due to gram-negative bacteria ［J］. N Engl J Med, 2010, 362 (19): 1804-1813.
［13］Gioannini TL, Weiss JP. Regulation of interactions of Gram-negative bacterial endotoxins with mammalian cells ［J］. Immunol Res, 2007, 39 (1-3): 249-260.
［14］Janeway CA Jr, Medzhitov R. Innate immune recognition ［J］. Annu Rev Immunol, 2002, 20: 197-216.
［15］郭萌, 李冠民, 黄清泉. 细菌内毒素研究进展［J］. 中国实验动物学报, 2009, 17(5): 397-401.
［16］陈洁, 姜虹. TLR4信号通路与炎性反应［J］. 医学综述, 2009,15(19): 2902-2904.
［17］Ishida Y, Agata Y, Shibahara K, Honjo T. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death ［J］. EMBO J, 1992, 11 (11): 3887-3895.
［18］Okazaki T, Honjo T. The PD-1-PD-L pathway in immunological tolerance ［J］. Trends Immunol, 2006, 27 (4): 195-201.
［19］Prokunina L, Padyukov L, Bennet A, de FU, Wiman B, Prince J, et al. Association of the PD-1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope ［J］. Arthritis Rheum, 2004, 50 (6): 1770-1773.
［20］Nielsen C, Hansen D, Husby S, Jacobsen BB, Lillevang ST. Association of a putative regulatory polymorphism in the PD-1 gene with susceptibility to type 1 diabetes ［J］. Tissue Antigens, 2003, 62 (6): 492-497.
［21］Kong EK, Prokunina-Olsson L, Wong WH, Lau CS, Chan TM. AlarconRiquelme M, et al. A new haplotype of PDCD1 is associated with rheumatoid arthritis in Hong Kong Chinese ［J］. Arthritis Rheum, 2005, 52 (4): 1058-1062.